Recurrent Adamantinomatous Craniopharyngioma Clinical Trials in Washington D.C., District of Columbia
2 recruitingWashington D.C., District of Columbia
Showing 1–2 of 2 trials
Recruiting
Phase 2
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Adamantinomatous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma
Nationwide Children's Hospital30 enrolled14 locationsNCT05233397
Recruiting
Phase 2
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Adamantinous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma
Nationwide Children's Hospital38 enrolled10 locationsNCT05286788